Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-11-049395)

Filing Details

Accession Number:: 0001181431-11-049395
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-09-15 14:10:44
Reporting Period:: 2011-09-15

Filing Date:: 2011-09-15
Accepted Time:: 2011-09-15 14:10:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
926617	Vermillion Inc.	VRML	In Vitro & In Vivo Diagnostic Substances (2835)	330595156

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1502237	Ashish Kohli	C/O Vermillion, Inc. 12117 Bee Caves Rd Building Three, Suite 100 Austin TX 78738	Vp Of Corporate Strategy	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-09-15	200	$2.99	11,700	No	4	P	Direct
Common Stock	Acquisiton	2011-09-15	1,800	$3.01	13,500	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The two purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2011.